SAIA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 5.507
EU - Europa 4.121
AS - Asia 1.923
AF - Africa 376
SA - Sud America 20
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.956
Nazione #
US - Stati Uniti d'America 5.496
GB - Regno Unito 1.038
IT - Italia 806
SE - Svezia 616
DE - Germania 556
CN - Cina 533
VN - Vietnam 531
SG - Singapore 454
IN - India 254
UA - Ucraina 236
IE - Irlanda 235
FR - Francia 151
RU - Federazione Russa 131
TG - Togo 112
BG - Bulgaria 88
CI - Costa d'Avorio 85
EE - Estonia 82
NG - Nigeria 79
ZA - Sudafrica 76
JO - Giordania 75
CH - Svizzera 65
BE - Belgio 30
IR - Iran 27
FI - Finlandia 25
SC - Seychelles 21
JP - Giappone 16
BR - Brasile 11
CA - Canada 11
AT - Austria 9
NL - Olanda 9
KR - Corea 8
HR - Croazia 7
AU - Australia 6
RO - Romania 6
GR - Grecia 5
AR - Argentina 4
DK - Danimarca 4
ES - Italia 4
MK - Macedonia 4
PL - Polonia 4
TR - Turchia 4
CL - Cile 3
LB - Libano 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EG - Egitto 2
HU - Ungheria 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HK - Hong Kong 1
IS - Islanda 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
TW - Taiwan 1
Totale 11.956
Città #
Southend 950
Fairfield 630
Chandler 618
Ashburn 430
Singapore 395
Woodbridge 292
Wilmington 291
Seattle 282
Houston 269
Princeton 258
Ann Arbor 247
Dublin 235
Cambridge 205
Dong Ket 205
Jacksonville 145
Lomé 112
Bologna 108
Turin 104
Westminster 103
Berlin 97
Padova 90
Santa Clara 87
Sofia 87
Nanjing 86
Abidjan 85
Abeokuta 79
Bremen 76
Amman 75
New York 71
Beijing 65
Milan 58
Bern 56
San Diego 52
Boardman 47
Jinan 45
Shenyang 42
Changsha 41
Dearborn 40
Saint Petersburg 40
Nanchang 35
Hebei 33
Rome 31
Brussels 29
Mülheim 27
Pune 26
Los Angeles 24
Helsinki 23
Medford 23
Olalla 21
Tianjin 21
Jiaxing 20
Mahé 19
Mountain View 19
Des Moines 18
Falls Church 18
Florence 18
Norwalk 17
Kuban 16
Lanzhou 14
Tokyo 14
Zhengzhou 14
Haikou 13
Redmond 13
Verona 13
Taizhou 12
Hangzhou 11
Leawood 11
Taiyuan 11
Ardabil 10
Ningbo 10
Paris 10
San Venanzo 10
Bühl 9
Guangzhou 9
London 9
Redwood City 9
Zanjan 8
Kunming 7
São Paulo 7
Washington 7
Andover 6
Hefei 6
Monmouth Junction 6
Napoli 6
Fuzhou 5
Genoa 5
Parma 5
Perugia 5
Phoenix 5
Russi 5
Toronto 5
Cernusco sul Naviglio 4
Changchun 4
Costa Mesa 4
Guri-si 4
Lausanne 4
Lonigo 4
Naples 4
Pavia 4
Reggio Emilia 4
Totale 7.962
Nome #
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 183
[Cognitive and quality of life trajectory after either surgical or transcatheter aortic valve replacement in high-risk patients] 178
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 171
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 167
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 159
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 156
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 155
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 155
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 154
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 150
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 143
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 142
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 140
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 139
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 135
null 134
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 132
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 131
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 129
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 127
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 127
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 126
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 126
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 125
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 125
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 124
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 123
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 122
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 121
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 121
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 119
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 119
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 118
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 117
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 117
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 117
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 117
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 115
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 114
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 112
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 111
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 111
Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. 110
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 109
La rete per il trattamento dell’infarto miocardico acuto con sopraslivellamento del tratto ST in Italia. Risultati della rilevazione RETE IMA WEB 107
[Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study] 107
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 107
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 106
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 106
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 105
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 105
Transcatheter Mitral Valve-in-Valve Dislocation: A Rescue Strategy 105
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 104
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 104
La qualità di vita dopo impianto transcatetere di valvola aortica: revisione e valutazione critica della letteratura [Quality of life after transcatheter aortic valve implantation: a Comprehensive literature review and critical appraisal] 104
The safety of drug-eluting stents. 102
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 102
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 102
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 100
Ogni lungo viaggio inizia con un piccolo passo: Il Signor C e la cardiologia interventistica 100
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with tirofiban or Abciximab [FATA] trial) 99
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 98
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 98
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 97
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 97
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 96
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 95
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 95
Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction 94
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 93
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 92
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 91
Twelve-Month Outcome of Patients with an Established Indication for Oral Anticoagulation Undergoing Coronary Artery Stenting and Stratified by the Baseline Risk of Bleeding. Insights from the Warfarin and Coronary Stenting (War-Stent) Registry 91
[Bioresorbable vascular scaffolds: clinical experience of the Emilia-Romagna Region, Italy] 90
Biolimus-a9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 89
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 88
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 87
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 87
null 86
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 86
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 86
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 84
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 84
Valve-in-valve technique to manage acute paraprosthetic leak after transcatheter aortic valve implantation. 81
Imaging Myocardium at Risk and Coronary Inflammation in Non-ST-Segment Elevation Myocardial Infarction: Combined Use of FDG PET and Optical Coherence Tomography. 81
Effect of fluvastatin on long-term outcome after coronary revascularization with stent implantation. 81
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 81
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 79
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 77
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 77
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 76
[The HEAT-PPCI study] 76
Displacement of calcium nodules of the native valve as a possible cause of left main occlusion following transcatheter aortic valve implantation. 74
Impact of coronary bypass or stenting on mortality and myocardial infarction in stable coronary artery disease 72
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 71
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 71
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 71
Correlation between aortic root dimension and coronary ectasia 70
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent: How Important Is the Interplay Between Stent Type and Time From Stenting to Surgery? 69
Predictors of beta-brachytherapy failure in patients with high-risk in-stent restenosis 68
Totale 10.870
Categoria #
all - tutte 31.877
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.877


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.193 0 0 37 155 246 271 324 342 350 196 103 169
2020/20211.591 325 97 38 67 14 65 31 69 157 82 64 582
2021/20222.277 176 107 130 197 178 115 44 151 79 201 493 406
2022/20233.103 269 434 165 374 250 230 81 185 577 86 273 179
2023/2024923 80 131 41 103 64 252 37 61 24 64 25 41
2024/2025816 187 537 92 0 0 0 0 0 0 0 0 0
Totale 12.353